MedTrace Logo

A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation

NCT02820714 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-09-28

No results posted yet for this study

Summary

The objective of this study is to evaluate BLI801 laxative in adults experiencing non-idiopathic constipation.

Conditions

Interventions

DRUG

BLI801 Laxative

BLI801 Laxative

Sponsors & Collaborators

  • Braintree Laboratories

    lead INDUSTRY

Principal Investigators

  • John McGowan · Braintree Laboratories, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02820714 on ClinicalTrials.gov